FMA
CLB icon

FNY Managed Accounts’s Core Laboratories CLB Stock Holding History

FNY Managed Accounts’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,070
Closed -$123K – 243
2017
Q1 		$123K Buy
+1,070
New +$124K 0.38% 54

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FNY Managed Accounts's CLB Position: Q2 2017 in Review

FNY Managed Accounts sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 1,070 shares — an estimated $123K sold.

FNY Managed Accounts first reported a position in CLB in Q1 2017 and held it in 1 quarter. The position peaked at $123K in Q1 2017. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • FNY Managed Accounts reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 1,070 Core Laboratories shares in Q2 2017, an estimated $123K.
  • FNY Managed Accounts first reported a position in Core Laboratories in Q1 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Core Laboratories position peaked at $123K in Q1 2017.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.